FRAZIER LIFESCIENCES ACQUISITION CORPORATION Quotes Frazier Lifesciences Acquisition Corporation
Equities
NAMS
NL00150012L7
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.15 EUR | -10.21% |
|
-3.73% | +70.99% |
| 15/05 | TD Cowen Starts NewAmsterdam Pharma With Buy Rating | MT |
| 09/05 | Earnings Flash (NAMS) NEWAMSTERDAM PHARMA N.V. Reports Q1 Revenue $1.4M | MT |
Quotes 5-day view
End-of-day quote Nasdaq| 21/05/2024 | 22/05/2024 | 23/05/2024 | 24/05/2024 | 28/05/2024 | |
|---|---|---|---|---|---|
| Last | 19.48 € | 19.58 € | 19.1 € | 18.82 € | 19.1 € |
| Volume | 53 484 | 139 267 | 35 045 | 131 706 | 35 045 |
| Change | -1.81% | +0.51% | -2.45% | -1.47% | -10.21% |
| Opening | 19.59 | 19.33 | 19.85 | 19.11 | 19.85 |
| High | 20.21 | 20.07 | 20.17 | 20.33 | 20.17 |
| Low | 19.01 | 19.10 | 19.04 | 18.51 | 19.04 |
Performance
| 1 day | -10.21% | ||
| 1 week | -3.73% | ||
| Current month | -12.43% | ||
| 1 month | -13.14% | ||
| 3 months | -21.17% | ||
| 6 months | +93.71% | ||
| Current year | +70.99% | ||
| 1 year | +40.75% | ||
| 3 years | +95.30% |
Volumes
marketsDaily volume
35 045
Avg. Volume 20 sessions
109 958
Avg. Volume 20 sessions
1 885 779.70
Avg. Volume 20 sessions USD
2 048 937.36
Record volume 1
2 900 962
Record volume 2
2 571 785
Record volume 3
1 904 169
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
1 558 675 822
Capitalization (USD)
1 693 532 454
Net sales (EUR)
13 005 070
Net sales (USD)
14 130 269
Number of employees
40
Sales / Employee (EUR)
325 127
Sales / Employee (USD)
353 257
Free-Float
94.29 %
Free-Float capitalization (EUR)
1 469 576 359
Free-Float capitalization (USD)
1 596 724 105
Average Daily Capital Traded
0.12%
Highs and lows
1 week
18.51
20.33
1 month
18.5123.01
Current year
11.1826.35
1 year
5.6326.35
3 years
5.6332.88
5 years
5.6332.88
10 years
5.6332.88
Indicators
Moving average 5 days
19.62
Moving average 20 days
20.98
Moving average 50 days
21.08
Moving average 100 days
20.46
Price spread / (MMA5)
+14.40%
Price spread / (MMA20)
+22.33%
Price spread / (MMA50)
+22.92%
Price spread / (MMA100)
+19.30%
STIM
RSI 9 days
28.61
RSI 14 days
35.52
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -10.21% | -3.73% | +70.99% | +40.75% | 1.69B | ||
| -2.11% | +1.09% | +9.81% | +37.36% | 118B | ||
| -1.75% | -2.80% | +9.99% | +32.59% | 106B | ||
| -3.95% | +1.16% | -11.75% | -10.75% | 23.4B | ||
| -1.40% | +2.40% | -1.69% | -10.04% | 22.1B | ||
| -1.05% | -3.37% | -10.23% | -29.55% | 18.34B | ||
| -0.38% | -5.46% | -41.92% | -35.99% | 16.59B | ||
| -0.16% | -9.29% | -15.81% | -33.48% | 15.97B | ||
| +0.60% | -0.47% | +6.17% | +55.24% | 14.03B | ||
| -9.88% | -14.27% | +14.80% | -11.31% | 11.67B | ||
| -0.53% | -4.49% | -31.81% | -35.97% | 7.55B | ||
| -1.13% | -2.08% | -3.54% | +25.69% | 7.53B | ||
| +0.05% | -6.87% | +9.22% | +40.61% | 7.48B | ||
| -2.97% | +2.47% | -0.05% | +46.75% | 7.48B | ||
| +3.22% | +0.92% | +248.31% | +214.05% | 6.92B | ||
| -1.01% | -16.38% | -60.34% | -72.67% | 6.31B | ||
| Average | -2.05% | -3.31% | +12.01% | +15.83% | ||
| Weighted average by Cap. | -1.87% | -0.26% | +5.85% | +20.53% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +68.49% | ||
| 2023 | +2.48% | ||
| 2022 | +11.79% | ||
| 2021 | -9.72% |
- Stock Market
- Equities
- NAMS Stock
- Quotes Frazier Lifesciences Acquisition Corporation
